Cervical Cancer Screening Should Continue after 65
|
By HospiMedica International staff writers Posted on 18 May 2017 |

Image: The Pap test is the most common form of cervical screening (Photo courtesy of Alamy).
A new study suggests that women without a hysterectomy and women over 65 who have not been recently screened may benefit from continued surveillance for cervical cancer (CC).
Researchers at the U.S. Centers for Disease Control and Prevention conducted a study that examined recent CC incidence data from the U.S. 2013 and 2015 National Health Interview Survey (NHIS) federal cancer surveillance programs for all women by age and race, corrected for hysterectomy status. They then calculated the proportion of women aged 41–70 years without a hysterectomy who reported that they never had a Papanicolaou (Pap) test or that their most recent Pap test was at least five years previously.
The results revealed that when corrected for hysterectomy, incidence rates of CC increased with age until 70 years, and did not begin to decline until age 85. In addition, many women approaching the accepted "stopping" age of 65 were not getting sufficient screening, and that the proportion of women not recently screened increases with age. While only 12% of women in their 40s had no recent screening history, that number progressively increased for women in their 50s and 60s. Nearly 850,000 women aged 61-65 years had not been screened within the last five years. The study was published on May 1, 2017, in the American Journal of Preventive Medicine.
“A recommended upper age limit for routine screening may lead women and providers to assume that cervical cancer is a younger women's disease. After adjustment for hysterectomy, some of the highest cervical cancer incidence rates occur among women older than 65 years, with notably higher rates among older black women,” said lead author epidemiologist Mary White, ScD, of the Division of Cancer Prevention and Control at the CDC. “Women who have not had a hysterectomy need to continue to be screened until age 65, and possibly later if they have not been screened for many years or are at special risk.
Cervical cancer arises from the cervix; it typically develops from precancerous changes over 10-20 years. Symptoms may include abnormal vaginal bleeding, pelvic pain, or pain during sexual intercourse. Human papillomavirus (HPV) infection causes more than 90% of cases, with other risk factors include smoking, a weak immune system, birth control pills, many sexual partners, and starting sex at a young age. CC diagnosis is typically by cervical screening followed by a biopsy.
Researchers at the U.S. Centers for Disease Control and Prevention conducted a study that examined recent CC incidence data from the U.S. 2013 and 2015 National Health Interview Survey (NHIS) federal cancer surveillance programs for all women by age and race, corrected for hysterectomy status. They then calculated the proportion of women aged 41–70 years without a hysterectomy who reported that they never had a Papanicolaou (Pap) test or that their most recent Pap test was at least five years previously.
The results revealed that when corrected for hysterectomy, incidence rates of CC increased with age until 70 years, and did not begin to decline until age 85. In addition, many women approaching the accepted "stopping" age of 65 were not getting sufficient screening, and that the proportion of women not recently screened increases with age. While only 12% of women in their 40s had no recent screening history, that number progressively increased for women in their 50s and 60s. Nearly 850,000 women aged 61-65 years had not been screened within the last five years. The study was published on May 1, 2017, in the American Journal of Preventive Medicine.
“A recommended upper age limit for routine screening may lead women and providers to assume that cervical cancer is a younger women's disease. After adjustment for hysterectomy, some of the highest cervical cancer incidence rates occur among women older than 65 years, with notably higher rates among older black women,” said lead author epidemiologist Mary White, ScD, of the Division of Cancer Prevention and Control at the CDC. “Women who have not had a hysterectomy need to continue to be screened until age 65, and possibly later if they have not been screened for many years or are at special risk.
Cervical cancer arises from the cervix; it typically develops from precancerous changes over 10-20 years. Symptoms may include abnormal vaginal bleeding, pelvic pain, or pain during sexual intercourse. Human papillomavirus (HPV) infection causes more than 90% of cases, with other risk factors include smoking, a weak immune system, birth control pills, many sexual partners, and starting sex at a young age. CC diagnosis is typically by cervical screening followed by a biopsy.
Latest Patient Care News
- Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
- Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
- VR Training Tool Combats Contamination of Portable Medical Equipment
- Portable Biosensor Platform to Reduce Hospital-Acquired Infections
- First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
- Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

- Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
- Next Gen ICU Bed to Help Address Complex Critical Care Needs
- Groundbreaking AI-Powered UV-C Disinfection Technology Redefines Infection Control Landscape
- Clean Hospitals Can Reduce Antibiotic Resistance, Save Lives
- Smart Hospital Beds Improve Accuracy of Medical Diagnosis
- New Fast Endoscope Drying System Improves Productivity and Traceability
- World’s First Automated Endoscope Cleaner Fights Antimicrobial Resistance
- Portable High-Capacity Digital Stretcher Scales Provide Precision Weighing for Patients in ER
- Portable Clinical Scale with Remote Indicator Allows for Flexible Patient Weighing Use
- Innovative and Highly Customizable Medical Carts Offer Unlimited Configuration Possibilities
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read moreSurgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







